These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 929152)

  • 21. Treatment of clozapine-induced agranulocytosis with recombinant granulocyte colony-stimulating factor.
    Gullion G; Yeh HS
    J Clin Psychiatry; 1994 Sep; 55(9):401-5. PubMed ID: 7523362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clozapine-induced agranulocytosis in Finland, 1982-2007: long-term monitoring of patients is still warranted.
    Lahdelma L; Appelberg B
    J Clin Psychiatry; 2012 Jun; 73(6):837-42. PubMed ID: 22480452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FDA's position on the clozaril patient management system.
    Peck CC
    Hosp Community Psychiatry; 1990 Aug; 41(8):876-7. PubMed ID: 2401475
    [No Abstract]   [Full Text] [Related]  

  • 24. [Agranulocytosis in the course of clozapine treatment].
    Załuska M; Gajewska J
    Psychiatr Pol; 1995; 29(1):67-77. PubMed ID: 7878156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clozapine-induced agranulocytosis. A genetic and epidemiologic study.
    de la Chapelle A; Kari C; Nurminen M; Hernberg S
    Hum Genet; 1977 Jun; 37(2):183-94. PubMed ID: 885538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry.
    Honigfeld G; Arellano F; Sethi J; Bianchini A; Schein J
    J Clin Psychiatry; 1998; 59 Suppl 3():3-7. PubMed ID: 9541331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clozapine and agranulocytosis].
    Xu SH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Oct; 17(5):271-2. PubMed ID: 6537285
    [No Abstract]   [Full Text] [Related]  

  • 28. Notes from a state mental health directors' meeting on clozapine.
    Salzman C
    Hosp Community Psychiatry; 1990 Aug; 41(8):838-9, 842. PubMed ID: 2401474
    [No Abstract]   [Full Text] [Related]  

  • 29. [Studies on side-effects in treatment of psychoses with clozapine (Leponex)].
    Kirkegaard A; Jensen A
    Ugeskr Laeger; 1977 Nov; 139(47):2800-5. PubMed ID: 595167
    [No Abstract]   [Full Text] [Related]  

  • 30. [A case of neutropenia and agranulocytosis induced by clozapine. The importance of a drug surveillance program for their early detection].
    Alfaro J; Berdichevsky E; Conte G; Tellez C
    Rev Med Chil; 1994 Jun; 122(6):694-8. PubMed ID: 7732216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clozapine: the commitment to patient safety.
    Alphs LD; Anand R
    J Clin Psychiatry; 1999; 60 Suppl 12():39-42. PubMed ID: 10372610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Filgrastim treatment of three patients with clozapine-induced agranulocytosis.
    Lamberti JS; Bellnier TJ; Schwarzkopf SB; Schneider E
    J Clin Psychiatry; 1995 Jun; 56(6):256-9. PubMed ID: 7539786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The incidence of clozapine-induced leukopenia in patients with schizophrenia at Srinagarind Hospital.
    Maskasame S; Krisanaprakornkit T; Khiewyoo J
    J Med Assoc Thai; 2007 Oct; 90(10):2175-80. PubMed ID: 18041439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agranulocytosis: incidence and risk factors.
    Alvir JM; Lieberman JA
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():137-8. PubMed ID: 7961558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?
    Kang BJ; Cho MJ; Oh JT; Lee Y; Chae BJ; Ko J
    Hum Psychopharmacol; 2006 Aug; 21(6):387-91. PubMed ID: 16933201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clozapine--a new and different neuroleptic.
    Haller E; Binder RL
    West J Med; 1990 Jul; 153(1):62-4. PubMed ID: 2389576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clozapine and resistant schizophrenia].
    Pere JJ; Chaumet-Riffaud D
    Encephale; 1990; 16(2):143-5. PubMed ID: 1972053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [EEG changes with leponex medication].
    Kursawe HK; Ludewig L
    Psychiatr Neurol Med Psychol (Leipz); 1985 Dec; 37(12):705-12. PubMed ID: 4095206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clozapine-induced agranulocytosis.
    Anger B; Reichert S; Heimpel H
    Blut; 1987 Jan; 54(1):63-4. PubMed ID: 3801680
    [No Abstract]   [Full Text] [Related]  

  • 40. [Leponex: experience of the hospital pharmacist].
    Gury C; Dechelette N; Gayral P
    Encephale; 1995 Jun; 21 Spec No 3():61-5. PubMed ID: 7628345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.